Advertisement
U.S. markets closed

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed Price. Currency in USD
129.45+0.19 (+0.15%)
At close: 04:00PM EST
130.00 +0.55 (+0.42%)
After hours: 07:58PM EST
  • Dividend

    MRK announced a cash dividend of 0.77 with an ex-date of Mar. 14, 2024

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close129.26
Open129.79
Bid129.67 x 800
Ask129.51 x 800
Day's Range128.86 - 130.24
52 Week Range99.14 - 130.24
Volume5,150,971
Avg. Volume8,527,409
Market Cap328.029B
Beta (5Y Monthly)0.39
PE Ratio (TTM)924.64
EPS (TTM)0.14
Earnings DateApr 25, 2024
Forward Dividend & Yield3.08 (2.38%)
Ex-Dividend DateMar 14, 2024
1y Target Est123.95
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
20% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for MRK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Merck & Company, Inc.
    Analyst Report: Merck & Co IncMerck & Co. is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has a leading vaccine business and an animal health division. MRK shares are included in the S&P 500.
    Rating
    Fair Value
    Economic Moat
    17 days agoArgus Research
View more